13F

Stock

Acumen Pharmaceuticals, Inc.

ABOS · held by 1 managers

Reported value

$51.9K

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$35K

Price effect on 1 books still in the name

Largest holder

$51.9K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC21.4K$51.9K−$35KCut−$139.7K

Positions as of Q2 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.